Depending on growth phase and culture conditions, cardiolipin (CL) makes up 5-15% of the phospholipids in Escherichia coli with the remainder being primarily phosphatidylethanolamine (PE) and phosphatidylglycerol (PG). In E. coli, the cls and ybhO genes (renamed clsA and clsB, respectively) each encode a CL synthase (Cls) that catalyzes the condensation of two PG molecules to form CL and glycerol. However, a ΔclsAB mutant still makes CL in the stationary phase, indicating the existence of additional Cls. We identified a third Cls encoded by ymdC (renamed clsC). ClsC has sequence homology with ClsA and ClsB, which all belong to the phospholipase D superfamily. The ΔclsABC mutant lacks detectible CL regardless of growth phase or growth conditions. CL can be restored to near wild-type levels in stationary phase in the triple mutant by expressing either clsA or clsB. Expression of clsC alone resulted in a low level of CL in the stationary phase, which increased to near wild-type levels by coexpression of its neighboring gene, ymdB. CL synthesis by all Cls is increased with increasing medium osmolarity during logarithmic growth and in stationary phase. However, only ClsA contributes detectible levels of CL at low osmolarity during logarithmic growth. Mutation of the putative catalytic motif of ClsC prevents CL formation. Unlike eukaryotic Cls (that use PG and CDP-diacylglycerol as substrates) or ClsA, the combined YmdB-ClsC used PE as the phosphatidyl donor to PG to form CL, which demonstrates a third and unique mode for CL synthesis.
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cardiolipin-deficient | bacteria | mass spectrometry T he anionic phospholipid cardiolipin (CL) (Fig. 1 ) is found primarily in energy-transducing membranes of most bacteria and almost exclusively in the mitochondria of eukaryotes, where it is essential for the optimal function of numerous enzymes involved in mitochondrial energy metabolism (1) . The near-neutral pK a of one of its two phosphate groups (2) has been postulated to function as a proton trap during oxidative phosphorylation. Alterations in CL metabolism are associated with Barth syndrome (3, 4) caused by mutations in tafazzin, a transacylase involved in remodeling of the CL acyl chains (5, 6) . Additionally, CL is involved in stabilization of higher order forms of the respiratory complexes (7, 8) , promoting the ribbon-like assembly of adenosine 5'-triphosphate synthase dimers and maintaining the high curvature of the mitochondrial cristae (9) .
Mutations in the cls gene (10) (now annotated clsA) that encodes a cardiolipin synthase (denoted herein as ClsA) in Escherichia coli results in reduced CL production accompanied by sensitization of cells to low osmolarity (11) and reduced viability in long-term stationary phase (12) . CL stabilizes the dimeric state of Sec-YEG protein channel complex (13) , promotes polar localization of ProP (14) , and activates respiratory complexes in E. coli (15) . CL levels increase when cells enter stationary phase due to a 10-fold increase in ClsA activity (12) . CL, a nonbilayer prone anionic lipid, is enriched at the cell poles and the cell division site (16) , forming anionic lipid domains involved in the organization of molecular machines on the membrane surface responsible for initiation of DNA replication and cell division (17) .
The pathway to CL biosynthesis in E. coli ( Fig. 1) and almost all bacteria proceeds from phosphatidic acid (PA) to cytidine diphosphate-diacylglycerol (CDP-DAG) then via phosphatidylglycerophosphate (PGP) synthase to PGP, which is dephosphorylated to PG (18) . The final step is a phosphatidyl transfer from one PG molecule to a second PG molecule to form CL and glycerol (19) catalyzed by a phospholipase D-type enzyme (ClsA) encoded by the clsA gene (10) . CDP-DAG also provides the precursor to the major phospholipid phosphatidylethanolamine (PE, 70%). However, in eukaryotic cells, CDP-DAG is the phosphatidyl donor to PG to yield CL and cytidine monophosphate (CMP) (Fig. 1) . A cls gene found in Streptomyces coelicolor and in most actinobacteria was recently shown to possess a CDP-DAG-dependent Cls (20) . Based solely on informatics analysis, Trypanosoma brucei was suggested to encode a bacterial-type Cls (1) . Thus, the terms prokaryotic-versus eukaryotic-type mechanism for CL synthesis may no longer be accurate.
Deletion of the clsA gene of E. coli resulted in no detectable CL in extracts of cells harvested during logarithmic growth in very low salt medium (1 g/L NaCl) (21, 22) . However, stationary phase cells still accumulated CL, which strongly suggests the existence of another Cls. Two clsA paralog genes, ybhO and ymdC, exist in E. coli. The clsB (previously known as ybhO) gene product (ClsB) was shown to catalyze CL formation in vitro, but attempts to show in vivo activity were not successful (21) . A double ΔclsAB mutant was constructed, but its lipid composition was not reported (23) .
In this report, we demonstrate that clsC (previously annotated as ymdC) encodes a third and possibly last Cls. Deletion of all three genes (ΔclsABC) resulted in a complete lack of CL. Each of the Cls contributes differently to the CL content under different growth conditions. Restoration of near-wild-type levels of CL production in the stationary phase by expression of clsC in the triple mutant requires the coexpression from the same operon of the preceding gene ymdB. Most significant is the demonstration that the mode of CL biosynthesis by the combined YmdB-ClsC follows neither the "eukaryotic" nor "prokaryotic" pathway but involves the transfer of a phosphatidyl moiety from PE to the terminal free hydroxyl of PG to form CL. Discovery of this third mode for CL biosynthesis has important implications for CL synthesis in many bacteria in which multiple cls genes have been identified mostly based on informatic analysis or incomplete substrate determination.
Results
Identification of Third cls Gene. To determine the remaining source of CL, we focused on clsC (ymdC), whose gene product is homologous to clsA and clsB gene products (21) . Each of the three proteins contains two HKD motifs characteristic of the phospholipase D superfamily ( Fig. S1 ) (21) . ClsC displays 23% identity and 39% similarity to ClsA and a 22% identity and 38% similarity to ClsB. However, sequence analysis did not predict any transmembrane helices in ClsC, unlike ClsA, which has two predicted transmembrane domains using the Phobius algorithm (24) . The clsC gene is located at the 23rd min of the E. coli genome, whereas clsA and clsB are at the 28th min and17th min, respectively. See Tables S1 and S2 for a detailed description of strains and plasmids, respectively.
The total lipids extracted from cells grown to stationary growth phase were analyzed by normal phase liquid chromatographytandem mass spectrometry (LC/MS/MS), which allowed the separation and identification of PG, CL (eluting at 13-14 min), monolyso CL, PE, PA, and bislyso CL (Fig. S2) . Unless otherwise noted, cells were grown at 37°C in rich LB medium containing 10 g/L NaCl. The corresponding mass spectra acquired during the CL time window ( Fig. 2A) Fig. 2A) , the ΔclsA (Fig. 2B ) and ΔclsAB mutants (Fig. 2C ) still accumulated CL in the stationary phase with an increase in the PG species contrary to previous results for the latter (21) . The ΔclsABC mutant displayed a complete disappearance of CL, monolyso CL, and bislyso CL while maintaining elevated PG (Fig. 2D and Fig. S2 ). The complete lack of CL substantiates clsC functioning as a Cls.
TLC analysis (Fig. S3 A and B) of stationary phase cells grown in 5 g/L NaCl and labeled with 5 μCi/mL of [ 32 P]PO 4 revealed the same defect found with mass spectrometry. WT cells contained the three major phospholipids, PE, PG, and CL, at the expected levels, and the triple deletion mutant showed no detectible CL. The area corresponding to CL (Fig. S3B ) registered a background level signal (X 1 = 0.02%); the faint spot (X 2 = 0.11%) indicates an above background signal. PE level was unchanged, and PG increased by the amount of CL loss.
The triple mutant, like the clsA single deletion mutant (12) , showed reduced viability during long-term incubation in the stationary phase, but no added effects were found when grown in LB medium at 37°C.
Expression of CL Synthases. The three cls genes with ribosomebinding sites were cloned into the arabinose inducible pBAD30 vector (25) and individually transformed into the ΔclsABC mutant. The transformants were grown to stationary (A 600 of ∼2.0) phase in medium with ampicillin and 0.2% arabinose for lipid analysis. By charring of the TLC plate, CL accumulation was seen with the overexpression of ClsA or ClsB (Fig. 3A) . Previous work could only confirm in vitro activity of ClsB (21) . The production of CL from the overexpression of ClsC was not be detected. However, MS analysis revealed small but measurable amounts of CL (Fig.  3B , Upper, Inset), confirming low in vivo ClsC activity.
The clsC gene is separated by one base pair in the same operon from the preceding gene, ymdB, which encodes a protein containing a macro domain with a predicted adenosine diphosphate (ADP) ribose-binding potential (26) . The entire two-gene operon was cloned into pBAD30. Co-overexpression of both proteins in the ΔclsABC mutant resulted in a CL level comparable to that with overexpression of clsA or clsB individually (Fig. 3 A and B, Lower). Further investigation as to the relationship between clsC and ymdB was carried out using LC/MS/MS lipid analysis. An alternative triple knockout BKT21 (ΔclsAB, ΔymdB::Kan R ) still contained CL, albeit at a greatly reduced level similar to the triple mutant complemented with a plasmid copy of clsC. However, complementation of BKT21 with a plasmid harboring only the ymdB gene did not increase CL levels over the vector control. Additionally, strain BKT22 (ΔclsABC, ΔymdB::Kan R ) still contained low levels of CL when clsC and ymdB were simultaneously expressed independently from different but compatible plasmids. Fig. 1 . CL biosynthetic pathways. The structural genes encoding the enzymes responsible for each step are indicated. In E. coli, clsA has been shown to condense two PG molecules to form CL. The clsB gene product also catalyzes the formation of CL in E. coli, but its substrates have not been definitively established. In yeast (31) , mammals (33) , and actinobacteria (20) , Cls (CRD1, hCLS1, and Sco1389 gene products, respectively) uses CDP-DAG and PG as substrates. The clsC gene product of E. coli catalyzes a third mode of CL synthesis, which is the subject of this report. (Fig. S3) .
However, coexpressing the cls and ymdB genes from the same operon (Fig. 3 ) fully complemented BKT22 with a high level of CL.
CL Levels in Single and Double Deletions in the cls Genes. All combinations of WT, single, double, and triple chromosomal deletions of cls were grown to both midlog phase (M) or stationary phase (S) in the presence or absence of 5 μCi/mL of [ 32 P]PO 4 in LB medium containing 5 g/L or 10 g/L NaCl, respectively. TLC analysis of radiolabeled lipids from cells in logarithmic growth ( Fig. 4A and Table S2 , M rows) showed high levels of CL (∼5%) only in strains expressing clsA. The strains lacking clsA, including the triple cls null strain, displayed a trace spot (0.3-0.6%) with mobility similar to CL. This trace spot detected in ΔclsABC was scraped and extracted using Bligh-Dyer solvents. LC/MS/MS analysis indicated the only major lipid species to be undecaprenylphosphate (C 55 -P) (m/z 845.663) and decaprenyl-phosphate (C 50 -P) (m/z 777.607). No spot corresponding to CL was detected when 2D TLC was used to analysis midlog phase cells lacking clsA or the ΔclsABC mutant in stationary phase (Fig. S4) . The TLC analysis of radiolabeled lipids extracted from cells grown to stationary phase (Fig. 4B and Table S2 , S rows) revealed that all mutants with the exception of the cls triple deletion mutant produced high levels of CL (∼11% except for ΔclsAC at 2.2%). Therefore, in logarithmic growth phase (in 5 g/L of NaCl), ClsA contributes all of the CL while ClsB and ClsC contribute no detectible CL. All Cls contribute CL in stationary phase.
For cells grown in 10 g/L of NaCl, LC/MS/MS was used for semiquantification of CL levels relative to PE by dividing the chromatographic peak areas of the most abundant CL (66:2) by the chromatographic peak area of the most abundant PE (16:0/ 16:1). Essentially the same results ( Fig. S5 A and B) were found, except CL was detected in the ΔclsA and ΔclsAB cells growing logarithmic phase. The effect of growth media composition is investigated in greater detail later.
Mutation of HKD Motifs of ClsC. To further substantiate that ClsC is a Cls, two HKD motifs characteristic of the phospholipase D superfamily were individually changed to H130A or H369A ( Fig. S1 ) and coexpressed in tandem with ymdB from plasmids introduced into the triple mutant. Lipids extracted from cells (OD 600 ∼0.5) and analyzed by one-dimensional TLC with charring ( The proportion of CL is increased in E. coli grown in medium with high osmolarity adjusted with either an ionic or a nonionic osmoticum, demonstrating that the range of osmolarity rather than the chemical nature of the osmoticum is important for up-regulation of CL biosynthesis (27) . All mutant combinations were radiolabeled in medium containing 5 g/L NaCl and 0.6 M mannitol (28) and analyzed for lipid composition by 2D TLC at midlog phase (Table S2 , row M*); WT cells and all mutant combinations except ΔclsABC showed increased CL when grown in high (M*) versus low (M) osmolarity medium. In high osmolarity medium, mutants expressing only clsA, clsC, or clsB showed 12%, 2.6%, or 0.3% CL, respectively. Single deletions in these genes contained 2.2%, 15%, or 12% CL, respectively, versus 16% for WT cells. Therefore, only ClsA makes detectible CL in low-osmolarity medium during logarithmic growth and contributes the majority of CL in high-osmolarity medium.
Previously Undescribed Mechanism for ClsC. To investigate the mode of CL synthesis by the coexpressed YmdB-ClsC, we constructed an E. coli mutant that cannot make PG (UE54, ΔpgsA) and also lacked all four genes (ΔclsABC, ΔymdB::Kan R ) associated with CL synthesis (BKT29) (Fig. 1 ). Plasmids expressing ClsA or YmdB-ClsC (as an operon) were transformed into BKT29. These strains were grown to stationary phase with 0.05% arabinose, and the CL synthetic capability of the membrane fraction was determined using synthetic phospholipids (5 μM) with unnatural fatty acid composition as substrates.
Extracts Fig. 3 . ClsC needs YmdB to fully complement CL synthesis. Cls were expressed from plasmid pBAD30 in ΔclsABC strain BKT12, induced with 0.2% arabinose, and grown to stationary phase. (A) One-dimensional TLC developed with solvent 4 followed by charring revealed clsA (pBAD30-A) and clsB (pBAD30-B) restored CL production, whereas clsC (pBAD30-C) could only produce a trace amount of CL; no CL was detected in the vector control (VC). Coexpression from the same promoter (pBAD30-YC) of both ymdB and its neighbor clsC restored CL levels to higher levels than clsC by itself. (B) Lipid extracts from strains carrying plasmid pBAD-C or pBAD-YC were analyzed by LC/MS/MS. Vector control showed no CL production, whereas clsC expression alone only produced trace amounts of CL, with its doubly charged ion peaks being magnified in the boxed inset. Expression of ymdB-clsC resulted in high levels of CL production (Lower). Fig. 4 . Growth phase dependence of CL synthesis in cls mutants grown in 5 g/L NaCL. WT or the indicated cls deletion strains were grown in LB medium containing 5 g/L of NaCl and [ 32 P]PO 4 to either midlog phase (A, OD 600 of 0.5-0.7) or to stationary phase (B, overnight culture). Phospholipids were extracted and separated by one-dimensional TLC using solvent 1 followed by imaging as described in the Materials and Methods. Results of quantification of radiolabeled spots are shown in Table S2 . The trace signal at the position of CL in A was not CL, as evidenced by lack of a CL species when the same samples were analyzed by 2D TLC (Fig. S4) . Only background signal at the position of CL was detected for the ΔclsABC strain in B.
Da; expected mass: 1320.910 Da) (Fig. 6A) . In addition, collision-induced dissociation MS/MS of the m/z 659.437 ion produced major ions at m/z 225.187 and m/z 269.249, corresponding to the carboxylic anions of C14:1 fatty acid and C17:0 fatty acid, respectively (Fig. 6B) . In contrast, cell extracts expressing YmdBClsC produced a heterogeneous distribution of CL species, with the major peaks being detected at m/z 666.448 for CL (63:2), m/z 673.459 for CL (64:1), and m/z 680.464 for CL (65:2) (Fig. 6C) . MS/MS analysis showed that the major CL species fatty acids were derived from synthetic PG and those of endogenous lipids in E. coli. For example, MS/MS spectrum ( PE and PA were the two major phospholipid species that might serve as phosphatidyl donors to PG. The same in vitro assay system was used with the addition of synthetic PG (12:0/13:0) and either synthetic PE or PA with 14:1/17:0 acyl chains in both cases (Fig. 7A shows the expected PE-derived CL). To determine whether phosphatidyl moieties from PE or PA were incorporated into CL without the interference of possible endogenous lipids, we used the multiple reaction monitoring (MRM) method performed on a triple quadrupole instrument in which the first (Q1) and last (Q3) mass analyzers were used as mass filters to ensure that only the expected CL species are detected. If ClsC uses the aforementioned substrates, the expected CL would have a doubly charged [M-2H] 2-ion at m/z 618.4 (Fig. 7A) , which is selected by the first mass filter. After the MS/MS collision cell, the last mass filter should isolate the m/z 225.2 (14:1) and 269.2 (17:0) ions, corresponding to the exogenous acyl chains derived from the synthetic substrates. With exogenous PA, PG, PE alone, or PG with PA, the expected CL species (14.8 min) with the respective fatty acyl compositions were not found (Fig. 7B) . However, the addition of exogenous PG and PE together in the assay mixture created a 500-fold increase in signal at 14.8 min when selecting for the expected mass and fatty acyl composition of CL (Fig. 7A) made from PE and PG (Fig. 7B) . The absence of signal with other combinations of exogenous phospholipids indicates that CL synthesis was dependent on ClsC with PG and PE as cosubstrates. low amounts of CL detected in ΔclsA strains was postulated to be a minor product of the pssA gene product (phosphatidylserine synthase) because the latter also contains the HKD phospholipase D motif (29) . However, our demonstration of a third gene, clsC, encoding ClsC and the absence of CL in a ΔclsABC mutant exclude this possibility. CL levels as a function of cls genes, growth phase of cells, and osmolarity of the growth medium fully explain many of the anomalies (including the above) with respect to CL synthesis. It is clear that growth conditions and genetic backgrounds must be carefully controlled when studying the role of CL in cell function.
The most remarkable finding was that ClsC, dependent on the HKD phospholipase D motifs, synthesized CL by a different mode using PE as the phosphatidyl donor to PG rather than CDP-DAG ("eukaryotic" mode) or a second PG ("bacterial" mode). Existence of this mode of synthesis challenges the simple informatics approach to classifying a Cls from all organisms as discussed for other bacteria below. A recent report from T. brucei suggested the presence of a bacterial-type Cls (30) based solely on informatics analysis without determination of in vitro synthase activity, so it is unclear which "prokaryotic" mode is used. All other eukaryotes, as exemplified by Saccharomyces cerivisiae (CRD1) (31) and human (CLS1) (32) genes, encode a Cls that uses CDP-DAG and PG as substrates (33, 34) . S. cerevisiae Δcrd1 strains lack CL but have not been analyzed under a wide spectrum of growth conditions to determine if other modes of CL synthesis may exist. Whether somatic cells or plant species contain alternative modes of CL synthesis remains an open question.
In many bacteria, either single or multiple genes are present that encode proteins with Cls activity and/or share homology with the E. coli cls genes. In only a few cases has PG independent of CDP-DAG been identified as a substrate and in no case has other phospholipid substrates been ruled out. In fact, previous in vitro determination of the substrates used by E. coli ClsB only established PG as a substrate and did not rule out involvement of membrane-derived PE as a second substrate (21) . We suspect that ClsB may use additional substrates and PG. The set of three homologous genes encoding Cls only exists in a few specific prokarya: Salmonella, Escherichia, and Shigella in Eneterobactera; Pseudomonia in Gammaproteobacteria; and Burkholderia and Bordetalla in Betaproteobacteria. Three cls paralogs (clsA [formerly known as ywnE], ywjE, and ywiE) have been identified in Bacillus subtilis, but only ywnE has been shown to encode a Cls with a dominant role in CL synthesis (35) . Interestingly, a triply null mutant of Bacillus subtilis still contains CL as determined by MS. Two genes (cls1 and cls2) encoding a Cls were identified in Staphylococcus aureus. These two genes together appear to account for nearly all CL formation, because deletion of both genes showed essentially no detectable CL accumulation in the stationary phase of growth (36) . Methanomicrobia of Archea maintains a single copy clsA homolog with conserved functional motifs. Although rare in eukarya, strong homologs of bacterial Cls exist in Caebirgabditis japonica and Ciona intestinalis, which most likely use a CDP-DAG independent mode of CL synthesis.
ClsC is the proposed catalytic component of a possible twoenzyme complex containing YmdB, which is also a remarkable finding for a Cls. ClsC contains the repetition of the HKD motif found in the two other Cls. Like ClsB, ClsC contains no predicted transmembrane helices; however, both activities were found in the membrane fraction, suggesting they are membrane-associated proteins. Like ClsA, ClsC overexpression is toxic to cells and can only be maintained by low induction. The role of YmdB in enhancing ClsC activity and necessity for transcription from the same polycistronic operon is unknown. The ymdBclsC operon is present in a group of bacteria that are closely related to E. coli, such as Salmonella, Shigella, Cronobacter, Citrobacter, and Enterobacter. YmdB belongs in the macro family of proteins, which is characterized by an ADP-binding domain (37) . In vitro studies show YmdB can deacetylate the sirtuin product of O-acetyl-ADP-ribose and reform ADP ribose in vitro (37) . The macro domain usually precedes the sirtuin gene as a neighbor. In this case, ymdB does not precede a sirtuin gene because ClsC was shown to be involved in CL synthesis. YmdB has also been shown to be an RNase III inhibitor by protein binding (38) .
Overall, we have shown that ClsC is a third and possibly last Cls of E. coli. Triple deletions of clsA, clsB, and clsC resulted in the complete depletion of CL in E. coli cells. The availability of the full complement of cls genes will facilitate studies of the regulation of CL biosynthesis and the physiologic importance of CL in E. coli and other bacteria. Most significant is the finding that YmdB-ClsC, an apparent unusual two-component complex, uses PG and PE in an unexpected mode of CL biosynthesis. This finding should stimulate more careful characterization of the multiple homologous cls genes in other bacteria and eukaryotic cells. Why E. coli has two modes for the synthesis of CL remains an intriguing question.
Materials and Methods
Mutants with multiple chromosomal deletions of cls genes were derived from the Keio single deletion collection. Lipid extraction was accomplished through an acidic Bligh-Dyer method. Total lipids were analyzed by either TLC or normal phase LC/MS using a QSTAR XL quadrupole time-of-flight tandem mass spectrometer (Applied Biosystems, Foster City, CA). The LC-MRM analysis for assaying the ClsC activity was carried out using a 4000 Q-Trap hybrid triple quadrupole linear ion-trap mass spectrometer equipped with a Turbo V ion source (Applied Biosystems Inc, Foster City, CA). Detailed protocols and reagents used and growth conditions are described in SI Materials and Methods. 4 . Antibiotics were added whenever necessary at concentrations of 50 μg/mL for kanamycin and 100 μg/mL for ampicillin. Strains were grown at 30°C or 37°C, and cell density was measured as absorption at 600 nm (A 600 ) by a DU spectrophotometer (Beckman Coulter). The pBAD30-derived (2) plasmids were grown with 0.2% L-(+)-arabinose unless indicated otherwise. Reagent grade chloroform, methanol, hydrochloric acid, sulfuric acid, isopropyl alcohol, and ethanol were purchased from Sigma. Synthetic phosphatidylglycerol (PG), phosphatidic acid (PA), phosphatidylethanolamine (PE), and CDP-diacylglycerol (CDP-DAG) were obtained from Avanti Polar Lipids, Inc.
Supporting Information
Bacterial Strain, Plasmids, and Molecular Biology Techniques. Escherichia coli W3110 is designated as the wild type (WT) with respect to its glycerophospholipid composition. All strains and plasmids with their corresponding genotypes are listed in Table S1 .
Genetic material was amplified by polymerase chain reaction (PCR) with KOD Hot Start DNA Polymerase (Novagen) following the manufacturer's protocols. Primers were synthesized by Integrated DNA Technology. Colony PCR was used to screen for appropriate colonies, and then the PCR products were sequenced at the DNA Analysis Facility of Duke University Health System. Plasmid transformations were accomplished using electroporation (3) or chemical transformation (4) . All genomic gene deletions and plasmid constructs were verified by PCR and DNA sequencing.
Construction of Chromosomal Mutants Lacking cls Genes. Mutants containing deletions of the cls genes were constructed using the Keio collection (5) of mutants (Table S1 ). In place of the gene of interest, Keio mutants harbor a kanamycin cassette flanked by two FLP recombinase sites, allowing for the excision of the cassette. P1 vir transduction was used to transfer these cassettes from the mutants to other strains (1). Multiple nonadjacent deletions were accomplished by excision of the initial kanamycin cassette. Kanamycin cassette incision used the plasmid pCP20 (6), which contains an Flp recombinase. This recombinase mediates the recombination of the two flanking FLP sequences ejecting the kanamycin sequence leaving only a FLP scar sequence. Transformants for pCP20 were selected for ampicillin resistance at 30°C. Colonies were purified twice at 42°C without antibiotics to cure the pCP20 plasmid. Strains were replica plated on plates without antibiotics and plates with ampicillin or kanamycin. Colonies that did not grow on plates with antibiotics were verified as deletions using PCR and DNA sequencing. The derived strains were subjected to another round of P1 vir transduction and elimination of the kanamycin marker to introduce additional null mutations. In the case of adjacent genes, PCR was used to synthesize a doublestranded DNA with a kanamycin cassette flanked by FLP regions, which are further flanked by 50 base pairs of the upstream and downstream regions of genes to be deleted. These linear DNA strands were transformed into strain DY330, which contains the λ red recombinase for efficient recombination (7). Once the deletions were confirmed in DY330, P1 transduction was used to move these deletions into the appropriate strains.
Strain BKT29 was derived from the strain of UE54 (ΔpgsA) in which PgsA (Fig. 1) is not expressed and additional mutations in lpp and rcsF are required for cell viability (8). UE54's kanamycin cassette was excised using the FLP recombinase found in pCP20. This yielded the strain BKT25 (MG1655 lpp2 Δara714 rcsF::mini-Tn10::Cam R ΔpgsA), which was subjected to successive P1 transductions.
Construction of Plasmids Containing cls Genes. Regions from W3110 containing clsA, clsB, clsC1, clsC1, or ymdB were amplified using PCR. These PCR products were digested with XbaI, SphI, or HindIII restriction enzymes where appropriate and ligated into similarly digested pBAD30 vectors using T4 DNA ligase following the manufacture's protocols. These products were transferred into DH5α competent cells by means of chemical transformation. The transformants were grown overnight at 37°C on LB plates with ampicillin as the selection antibiotic. Colonies were purified twice on ampicillin plates. The placement of each gene under araBAD promoter regulation was verified by PCR and DNA sequencing.
Each of the two His residues in the two putative catalytic HKD motifs (Fig. S1 ) of ClsC were mutated to Ala. Plasmid pBAD-YC (carrying ymdB-clsC) was subjected to PCR mutagenesis to generate plasmids pBAD-YC H130A or pBAD-YC H369A.
Complementation of the Triple cls Mutant. Strain BKT12 (ΔclsABC) transformed with plasmid pBAD30, pBAD-A, pBAD-B, pBAD-C, or pBAD-YC was grown overnight and diluted to an A 600 of 0.03 in LB media with 0.2% arabinose to induce cls gene expression. The strains were grown for 2 h to an A 600 of ∼0.5 for logarithmic growth phase cells or for 6 h to an A 600 of ∼2.0 for stationary phase cells. Cells were collected by centrifugation at 3,500 × g at 4°C and then washed with phosphate-buffered saline.
Lipid Extraction and TLC Analysis. Lipid extraction was accomplished through an acidic Bligh Dyer method (9) . Each sample pellet from 100 mL of culture was brought up in 2 mL of 0.1 N HCl. Then 5 mL of methanol and 2.5 mL of chloroform were added to the aqueous solution to create a single-phase solution consisting of chloroform/methanol/0.1 N HCl [1:2:0.8 (vol/vol)]. This solution was incubated for 30 min at room temperature with intermittent mixing. Afterward, 2.5 mL of 0.1 N HCl and 2.5 mL of chloroform were added to convert the single phase to a twophase solution consisting of chloroform/methanol/0.1 N HCl [2:2:1.8 (vol/vol)]. After centrifugation at 3000 × g for 25 min at room temperature, the lower phase was recovered and dried under a stream of nitrogen.
The dried lipid extract was resuspended in 100 μL of chloroform/ methanol (2:1, vol/vol) and subjected to sonication for 1 min. Approximately 1-5 μL of sample was subjected to TLC using a TLC or HPTLC 60 plate (EMD) developed with solvent 4 (consisting of chloroform/methanol/acetic acid [65:25:5 (vol/vol)]). After drying the plate, lipids were visualized by spraying with 10% sulfuric acid in ethanol (vol/vol) followed by charring on a hot plate.
To determine the steady-state phospholipid composition by radiolabeling, cells were uniformly labeled with 5 μCi/mL of [ 32 P]PO 4 either during overnight growth and after dilution to A 600 of 0.05 to initiate logarithmic growth or only after dilution of the overnight culture. Cells were harvested by centrifugation, and phospholipids were extracted as described above and analyzed after separation either by one-dimensional TLC on boric acid-impregnated silica gel plates in solvent 1 (chloroform/ methanol/water/ammonium hydroxide [60:37.5:3:1 (vol/vol)]) (10) silica gel-precoated TLC plates with a concentration-zone (Whatman) were impregnated for 1 min in 1.2% boric acid in ethanol-water (1:1) as previously described (10) . Radiolabeled lipids were visualized and quantified using a Personal Molecular Imager FX (Bio-Rad Laboratories). Stored images were processed and quantified using Quantity One software for scanning and analysis of the captured Phosphor images (Bio-Rad Laboratories). Phospholipid content is expressed as mol% of total phospholipid (correcting for two phosphates per molecule of CL) based on the intensity of the captured signal on Phosphor screen generated by the radiolabeled spots on the TLC plate. Values for quantified radiolabeled spots were rounded to two significant figures so totals are 100 ± 1%. Because many of the minor radiolabeled spots are unknown, they were not included in the quantification of phospholipid composition. The results presented are representative of two or more determinations. The elution program consisted of the following: 100% mobile phase A was held isocratically for 2 min and then linearly increased to 100% mobile phase B over 14 min and held at 100% B for 11 min. The LC gradient was then changed to 100% mobile phase C over 3 min and held at 100% C for 3 min and finally returned to 100% A over 0.5 min and held at 100% A for 5 min. The total LC flow rate was 300 μL/min. To achieve optimum ESI efficiency, a postcolumn splitter was used to divert ∼10% of the LC effluent into the mass spectrometer, a QSTAR XL quadrupole time-of-flight tandem mass spectrometer (MS/MS) (Applied Biosystems). Instrumental settings for negative ion ESI and MS/MS analysis of lipid species were as follows: ion spray voltage (IS) = −4500 V, curtain gas (CUR) = 20 psi, ion source gas 1 (GS1) = 20 psi, declustering potential (DP) = −55 V, and focusing potential (FP) = −150 V. MS/MS analysis used nitrogen as the collision gas. Data analysis was performed using analyst QS software (Applied Biosystem).
LC-Multiple Reaction Monitoring. For LC-multiple reaction monitoring (LC-MRM) analysis, the same LC conditions were used as above, but the effluent was analyzed with a 4000 Q-Trap hybrid triple quadrupole linear ion-trap mass spectrometer, equipped with a Turbo V ion source (Applied Biosystems). MRM was performed in the negative ion mode with MS settings as follows: curtain gas (CUR) = 20 psi, ion source gas 1 (GS1) = 20 psi, ion source gas 2 (GS2) = 30 psi, ion spray voltage (IS) = −4500 V, heater temperature (TEM) = 350°C, interface heater = ON, declustering potential (DP) = −40 V, entrance potential (EP) = −10 V, collision cell exit potential (CXP) = −5 V.
In Vitro Assay of CL Synthase. Strain BKT29 was created by introducing ΔclsA, ΔclsB, ΔclsC, and ymdB::Kan R into UE54 (after removal of its Kan R cassette), which is null for the pgsA gene (11) and therefore lacks the ability to make PG. The resulting BKT29 was transformed with plasmid pBAD30 as vector control or pBAD-A, -B, or -YC. These cells were grown to A 600 of ∼0.5 at 37°C and then induced for the respective cls gene expression with 0.05% arabinose. After induction, cells were grown for two more h until harvesting by centrifugation at 3500 × g at 4°C. The cells were then washed with 1 × PBS (pH 7.4). Afterward, the pellet was resuspended in 2 mL of 1 × PBS and lysed by passing through a French press at 18,000 psi. Cell-free lysates were collected by centrifugation at 22,000 × g for 20 min at 4°C. The membrane fraction was collected by further ultracentrifugation of the cell-free lysates at 266,000 × g at 4°C for 1 h. Pellets were collected and solubilized using a PTFE tissue grinder (VWR) in PBS. Protein concentration for these membranes was determined using a Pierce BCA assay (Thermo Scienific).
The reaction mixture of 100 μL consisted of PBS, 0.1% Triton X-100, 10 mM β-mercaptoethanol, 5 μM of synthetic, and 1 mg/mL cell membranes with the following synthetic phospholipid substrates at 5 μM as indicated in the Table S2 were subjected to 2D TLC using solvent 2 in the vertical direction followed by solvent 3 in the horizontal direction. Growth phase of cells in LB with 5 g/L NaCl was either stationary (sta) or midlog (log). All ΔclsA strains lack CL in log phase and ΔclsABC lacks CL in log and stationary phase. . Cultures were supplement with [ 32 P]PO 4 either during overnight growth and after dilution to A 600 of 0.05 to initiate log growth (B and D) or only after dilution of the overnight culture (A and C) to monitor only phospholipids synthesized during logarithmic growth. Quantification of phospholipid content after TLC as in Fig. 3A showed PE and PG to be 73% and 26%, respectively, in all panels, with CL detectible only in C and D at 0.6% of the three major phospholipids. 
